Which populations require caution with zolpidem due to next-day impairment and driving risk?

Which populations require caution with zolpidem due to next-day impairment and driving risk?

• A. Women, older adults, and individuals with liver impairment
• B. Young healthy men
• C. Children under 12
• D. People with anxiety disorders

Answer: (A)

Next-day impairment from zolpidem happens because the drug’s sedative effects can linger into the morning, and how quickly or slowly it clears from the body varies between people. The groups at higher risk are women, older adults, and people with liver impairment. In women, zolpidem tends to reach higher levels and clear more slowly, so residual drowsiness and slower reaction times can affect driving the next day. Older adults often have reduced drug metabolism and greater sensitivity to CNS depressants, increasing the chance of impaired alertness and coordination the following day. Liver impairment directly slows metabolism, leaving more drug in the system and prolonging sedation. Because of these factors, dosing is adjusted and driving should be avoided if any next-day impairment is suspected. Young healthy men generally metabolize and clear zolpidem more efficiently, so next-day impairment is less likely. Children under 12 are not typical candidates for zolpidem due to safety concerns, and anxiety disorders don’t inherently change the drug’s next-day driving risk in the same way as the listed groups.

Next-day impairment from zolpidem happens because the drug’s sedative effects can linger into the morning, and how quickly or slowly it clears from the body varies between people. The groups at higher risk are women, older adults, and people with liver impairment. In women, zolpidem tends to reach higher levels and clear more slowly, so residual drowsiness and slower reaction times can affect driving the next day. Older adults often have reduced drug metabolism and greater sensitivity to CNS depressants, increasing the chance of impaired alertness and coordination the following day. Liver impairment directly slows metabolism, leaving more drug in the system and prolonging sedation. Because of these factors, dosing is adjusted and driving should be avoided if any next-day impairment is suspected.

Young healthy men generally metabolize and clear zolpidem more efficiently, so next-day impairment is less likely. Children under 12 are not typical candidates for zolpidem due to safety concerns, and anxiety disorders don’t inherently change the drug’s next-day driving risk in the same way as the listed groups.